StockCV

Eli Lilly & Co. vs Novartis AG

LLY vs NVS — side-by-side comparison from reported financials. LLY leads 9, NVS leads 2 of 11 comparable metrics.

Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Novartis AG
NVS · Healthcare
$143.75+0.45%Solid
MetricLLYNVS
Price$1 177.20$143.75
Market cap$1.05T$273B
Revenue (TTM)$79.7B$56.7B
Revenue growth+31.7%+9.1%
Net margin33.5%24.7%
Free cash flow$18.2B$16.8B
Net cash (debt)($35.2B)($41.4B)
1-year price return+37.6%+9.7%
P/E41.620.3
P/E vs own history (cheap-side %)88%46%
Dividend yield0.52%3.49%
Return on equity93%30%
Altman Z-score7.103.50
CV checks passed11 of 1111 of 11
Employees50,00075,267

Full résumé-style profiles: LLY CV · NVS CV

Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.